182 related articles for article (PubMed ID: 29728446)
21. NecroX-5 suppresses IgE/Ag-stimulated anaphylaxis and mast cell activation by regulating the SHP-1-Syk signaling module.
Li X; Kwon O; Kim DY; Taketomi Y; Murakami M; Chang HW
Allergy; 2016 Feb; 71(2):198-209. PubMed ID: 26456627
[TBL] [Abstract][Full Text] [Related]
22. Mercury alters endogenous phosphorylation profiles of SYK in murine B cells.
Caruso JA; Carruthers N; Shin N; Gill R; Stemmer PM; Rosenspire A
BMC Immunol; 2017 Jul; 18(1):37. PubMed ID: 28716125
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of spleen tyrosine kinase attenuates allergen-mediated airway constriction.
Moy LY; Jia Y; Caniga M; Lieber G; Gil M; Fernandez X; Sirkowski E; Miller R; Alexander JP; Lee HH; Shin JD; Ellis JM; Chen H; Wilhelm A; Yu H; Vincent S; Chapman RW; Kelly N; Hickey E; Abraham WM; Northrup A; Miller T; Houshyar H; Crackower MA
Am J Respir Cell Mol Biol; 2013 Dec; 49(6):1085-92. PubMed ID: 23889698
[TBL] [Abstract][Full Text] [Related]
24. Inhibitory effects of mulberry fruit extract in combination with naringinase on the allergic response in IgE-activated RBL-2H3 cells.
Yoo JM; Kim NY; Seo JM; Kim SJ; Lee SY; Kim SK; Kim HD; Lee SW; Kim MR
Int J Mol Med; 2014 Feb; 33(2):469-77. PubMed ID: 24336971
[TBL] [Abstract][Full Text] [Related]
25. Inhibitors of switch kinase 'spleen tyrosine kinase' in inflammation and immune-mediated disorders: a review.
Kaur M; Singh M; Silakari O
Eur J Med Chem; 2013 Sep; 67():434-46. PubMed ID: 23917087
[TBL] [Abstract][Full Text] [Related]
26. Selective interleukin-1 receptor-associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancy.
Kelly PN; Romero DL; Yang Y; Shaffer AL; Chaudhary D; Robinson S; Miao W; Rui L; Westlin WF; Kapeller R; Staudt LM
J Exp Med; 2015 Dec; 212(13):2189-201. PubMed ID: 26621451
[TBL] [Abstract][Full Text] [Related]
27. Crystal structures of spleen tyrosine kinase in complex with novel inhibitors: structural insights for design of anticancer drugs.
Lee SJ; Choi JS; Han BG; Kim HS; Song HJ; Lee J; Nam S; Goh SH; Kim JH; Koh JS; Lee BI
FEBS J; 2016 Oct; 283(19):3613-3625. PubMed ID: 27504936
[TBL] [Abstract][Full Text] [Related]
28. Inhibitory effect of fermented Arctium lappa fruit extract on the IgE-mediated allergic response in RBL‑2H3 cells.
Yoo JM; Yang JH; Yang HJ; Cho WK; Ma JY
Int J Mol Med; 2016 Feb; 37(2):501-8. PubMed ID: 26707911
[TBL] [Abstract][Full Text] [Related]
29. Syk kinase as a treatment target for therapy in autoimmune diseases.
Kyttaris VC; Tsokos GC
Clin Immunol; 2007 Sep; 124(3):235-7. PubMed ID: 17662659
[TBL] [Abstract][Full Text] [Related]
30. Transfection of Syk protein tyrosine kinase reconstitutes high affinity IgE receptor-mediated degranulation in a Syk-negative variant of rat basophilic leukemia RBL-2H3 cells.
Zhang J; Berenstein EH; Evans RL; Siraganian RP
J Exp Med; 1996 Jul; 184(1):71-9. PubMed ID: 8691151
[TBL] [Abstract][Full Text] [Related]
31. [Syk inhibitors].
Kimura Y; Chihara K; Takeuchi K; Sada K
Nihon Rinsho; 2013 Jul; 71(7):1248-52. PubMed ID: 23961675
[TBL] [Abstract][Full Text] [Related]
32. Optimization of a series of potent, selective and orally bioavailable SYK inhibitors.
Grimster NP; Gingipalli L; Barlaam B; Su Q; Zheng X; Watson D; Wang H; Simpson I; Pike A; Balazs A; Boiko S; Ikeda TP; Impastato AC; Jones NH; Kawatkar S; Kemmitt P; Lamont S; Patel J; Read J; Sarkar U; Sha L; Tomlinson RC; Wang H; Wilson DM; Zehnder TE; Wang L; Wang P; Goldberg FW; Shao W; Fawell S; Dry H; Dowling JE; Edmondson SD
Bioorg Med Chem Lett; 2020 Oct; 30(19):127433. PubMed ID: 32717371
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of spleen tyrosine kinase prevents mast cell activation and airway hyperresponsiveness.
Matsubara S; Li G; Takeda K; Loader JE; Pine P; Masuda ES; Miyahara N; Miyahara S; Lucas JJ; Dakhama A; Gelfand EW
Am J Respir Crit Care Med; 2006 Jan; 173(1):56-63. PubMed ID: 16192454
[TBL] [Abstract][Full Text] [Related]
34. Selective spleen tyrosine kinase inhibition delays autoimmune arthritis in mice.
Zhang Z; Cao C; Sun S; Xu Q
Mol Med Rep; 2015 Aug; 12(2):2902-6. PubMed ID: 25955571
[TBL] [Abstract][Full Text] [Related]
35. VX-509 (decernotinib) is a potent and selective janus kinase 3 inhibitor that attenuates inflammation in animal models of autoimmune disease.
Mahajan S; Hogan JK; Shlyakhter D; Oh L; Salituro FG; Farmer L; Hoock TC
J Pharmacol Exp Ther; 2015 May; 353(2):405-14. PubMed ID: 25762693
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory effect of the branches of Hovenia dulcis Thunb. and its constituent pinosylvin on the activities of IgE-mediated mast cells and passive cutaneous anaphylaxis in mice.
Lim SJ; Kim M; Randy A; Nho CW
Food Funct; 2015 Apr; 6(4):1361-70. PubMed ID: 25804702
[TBL] [Abstract][Full Text] [Related]
37. Anti-adult T‑cell leukemia/lymphoma activity of cerdulatinib, a dual SYK/JAK kinase inhibitor.
Ishikawa C; Senba M; Mori N
Int J Oncol; 2018 Oct; 53(4):1681-1690. PubMed ID: 30066853
[TBL] [Abstract][Full Text] [Related]
38. Morin inhibits Fyn kinase in mast cells and IgE-mediated type I hypersensitivity response in vivo.
Kim JW; Lee JH; Hwang BY; Mun SH; Ko NY; Kim DK; Kim B; Kim HS; Kim YM; Choi WS
Biochem Pharmacol; 2009 May; 77(9):1506-12. PubMed ID: 19426688
[TBL] [Abstract][Full Text] [Related]
39. Polygoni cuspidati radix inhibits the activation of Syk kinase in mast cells for antiallergic activity.
Lim BO; Lee JH; Ko NY; Mun SH; Kim JW; Kim DK; Kim JD; Kim BK; Kim HS; Her E; Lee HY; Choi WS
Exp Biol Med (Maywood); 2007 Dec; 232(11):1425-31. PubMed ID: 18040066
[TBL] [Abstract][Full Text] [Related]
40. Effects of GS-9876, a novel spleen tyrosine kinase inhibitor, on platelet function and systemic hemostasis.
Clarke AS; Rousseau E; Wang K; Kim JY; Murray BP; Bannister R; Matzkies F; Currie KS; Di Paolo JA
Thromb Res; 2018 Oct; 170():109-118. PubMed ID: 30172129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
